Bernard Testa
#106,852
Most Influential Person Now
Researcher
Bernard Testa's AcademicInfluence.com Rankings
Bernard Testacomputer-science Degrees
Computer Science
#3929
World Rank
#4129
Historical Rank
Machine Learning
#618
World Rank
#625
Historical Rank
Artificial Intelligence
#821
World Rank
#834
Historical Rank
Database
#1172
World Rank
#1232
Historical Rank

Download Badge
Computer Science
Why Is Bernard Testa Influential?
(Suggest an Edit or Addition)Bernard Testa's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Advances in Drug Research (1964) (606)
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling (2007) (516)
- Molecular fields in quantitative structure–permeation relationships: the VolSurf approach (2000) (503)
- Inhibitors of Cytochrome P-450s and their mechanism of action. (1981) (387)
- Predicting blood-brain barrier permeation from three-dimensional molecular structure. (2000) (372)
- Lessons learned from marketed and investigational prodrugs. (2004) (354)
- Lipophilicity in drug action and toxicology (1996) (323)
- Predicting drug metabolism: experiment and/or computation? (2015) (305)
- In silico pharmacology for drug discovery: applications to targets and beyond (2007) (298)
- Lipophilicity and Its Relationship with Passive Drug Permeation (2011) (278)
- Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. (2001) (260)
- Molecular Lipophilicity Potential, a tool in 3D QSAR: Method and applications (1994) (243)
- Drug Metabolism: Chemical and Biochemical Aspects (1976) (241)
- Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs. (2000) (237)
- Assessing drug-likeness--what are we missing? (2008) (216)
- Hydrolysis in drug and prodrug metabolism : chemistry, biochemistry, and enzymology (2003) (204)
- Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity. (1991) (201)
- Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations. (1993) (179)
- The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples (2000) (178)
- Structure-property relationships of trimetazidine derivatives and model compounds as potential antioxidants. (1998) (168)
- Reactions and enzymes in the metabolism of drugs and other xenobiotics. (2012) (164)
- Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity. (1991) (164)
- The skin as a drug-metabolizing organ. (1978) (163)
- Percutaneous penetration of drugs: a quantitative structure-permeability relationship study. (1991) (153)
- Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques (2002) (142)
- The influence of stereochemical factors on drug disposition. (1973) (140)
- Quantitative Structure-Permeation Relationships (QSPeRs) to Predict Skin Permeation: A Critical Evaluation (2004) (139)
- Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline (1990) (136)
- An antifungal gamma-pyrone and xanthones with monoamine oxidase inhibitory activity from Hypericum brasiliense. (1994) (125)
- Racemization, Enantiomerization, Diastereomerization, and Epimerization - Their Meaning and Pharmacological Significance (1995) (122)
- Pharmacokinetic optimization in drug research (2001) (119)
- Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites. (1998) (118)
- Immobilized artificial membrane HPLC in drug research. (2003) (116)
- Computer-Assisted Lead Finding and Optimization (1997) (113)
- Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist. (1998) (112)
- Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. (1998) (111)
- Prodrug research: futile or fertile? (2004) (110)
- Lipophilicity measurements of protonated basic compounds by reversed-phase high-performance liquid chromatography : II. Procedure for the determination of a lipophilic index measured by reversed-phase high-performance liquid chromatography (1985) (109)
- Stereochemical Aspects of Drug Action and Disposition (1996) (107)
- Structural damage to proteins caused by free radicals: asessment, protection by antioxidants, and influence of protein binding. (2001) (105)
- Lipophilicity in Molecular Modeling (1996) (105)
- Liposome/water lipophilicity: Methods, information content, and pharmaceutical applications (2004) (103)
- The Biochemistry of Drug Metabolism – An Introduction (2007) (102)
- Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects (1994) (101)
- Lipophilicity Profiles of Ampholytes. (1997) (101)
- Ionic Partition Diagrams: A Potential−pH Representation (1996) (100)
- Lipophilicity measurements of protonated basic compounds by reversed-phase high-performance liquid chromatography : I. Relationship between capacity factors and the methanol concentration in methanol-water eluents (1985) (99)
- Chiral aspects of drug metabolism (1986) (99)
- Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition. (2014) (98)
- Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa. (1980) (96)
- Ligand specificity of the genetic variants of human alpha1-acid glycoprotein: generation of a three-dimensional quantitative structure-activity relationship model for drug binding to the A variant. (1998) (95)
- Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies (2006) (95)
- Physicochemical and Structural Properties of Non-Steroidal Anti-inflammatory Oxicams (1993) (94)
- Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes (1992) (94)
- Ionic partition diagrams of ionisable drugs : pH-lipophilicity profiles, transfer mechanisms and charge effects on solvation (1999) (93)
- The parametrization of lipophilicity and other structural properties in drug design (1987) (93)
- Determination of lipophilicity by reversed-phase high-performance liquid chromatography. Influence of 1-octanol in the mobile phase. (2005) (92)
- Electrochemical behaviour and antioxidant activity of some natural polyphenols (1996) (91)
- The Biochemistry of Drug Metabolism – An Introduction (2007) (90)
- Molecular Factors Influencing Retention on Immobilized Artificial Membranes (IAM) Compared to Partitioning in Liposomes and n-Octanol (2002) (88)
- Concepts in drug metabolism (1980) (86)
- Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver. (1998) (84)
- Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps. (2009) (82)
- Structure-Lipophilicity Relationships of Neutral and Protonated β-Blockers, Part I, Intra- and Intermolecular Effects in Isotropic Solvent Systems (1999) (81)
- Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid. (1997) (79)
- Very slow chiral inversion of clopidogrel in rats: a pharmacokinetic and mechanistic investigation. (2000) (78)
- Selective inhibitors of monoamine oxidase (MAO‐A and MAO‐B) as probes of its catalytic site and mechanism (1995) (77)
- QSAR: Hansch analysis and related approaches (1995) (76)
- Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonists. (2003) (76)
- Octan-1-ol–water partition coefficients of zwitterionic α-amino acids. Determination by centrifugal partition chromatography and factorization into steric/hydrophobic and polar components (1992) (75)
- Lipophilicity in Drug Action and Toxicology: Pliška/Lipophilicity (1996) (75)
- Screening of Non‐Alkaloidal Natural Compounds as Acetylcholinesterase Inhibitors (2004) (74)
- The so-called "interconversion" of stereoisomeric drugs: an attempt at clarification. (1993) (73)
- Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases. (1994) (72)
- Lipophilicity and solvation of anionic drugs. (2002) (71)
- Principles of organic stereochemistry (1979) (70)
- The Biochemistry of Drug Metabolism – An Introduction (2008) (70)
- The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors. (1986) (70)
- Intermolecular Forces Expressed in 1,2-Dichloroethane/Water Partition Coefficients: A Solvatochromic Analysis (1997) (69)
- Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships. (1998) (69)
- Charge and Delocalisation Effects on the Lipophilicity of Protonable Drugs (1999) (69)
- Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. (2002) (69)
- Evaluation and Prediction of Drug Permeation (1999) (68)
- The Biochemistry of Drug Metabolism – An Introduction (2006) (67)
- Predicting Drug Metabolism – An Evaluation of the Expert System METEOR (2005) (67)
- Racemates versus enantiomers in drug development: dogmatism or pragmatism? (1990) (67)
- Pharmacokinetics of β-adrenoceptor blockers in obese and normal volunteers (1997) (66)
- L‐Dopa Methyl Ester—A Candidate for Chronic Systemic Delivery of L‐Dopa in Parkinson's Disease (1984) (65)
- A simple model to predict blood-brain barrier permeation from 3D molecular fields. (2002) (63)
- Structural Properties Governing Retention Mechanisms on RP-HPLC Stationary Phases Used for Lipophilicity Measurements (1995) (63)
- Physicochemical Characterization of Sildenafil: Ionization, Lipophilicity Behavior, and Ionic-Partition Diagram Studied by Two-Phase Titration and Electrochemistry (2000) (62)
- Measurement of partition coefficients by various centrifugal partition chromatographic techniques : A comparative evaluation (1991) (61)
- Quantitative Structure–Permeation Relationships for Solute Transport Across Silicone Membranes (2002) (61)
- Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC. (1995) (61)
- Inhibition of monoamine oxidase-B by 5H-indeno[1,2-c]pyridazines: biological activities, quantitative structure-activity relationships (QSARs) and 3D-QSARs. (1995) (61)
- Mechanism of transfer of a basic drug across the water 1,2-dichloroethane interface: The case of quinidine (1996) (61)
- Natural and Synthetic Xanthones as Monoamine Oxidase Inhibitors: Biological Assay and 3D‐QSAR (2001) (60)
- Lipophilicity Behavior of Model and Medicinal Compounds containing a suilfide, sulfoxide, or sulfone moiety (1997) (59)
- Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (1995) (58)
- Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors? (1987) (57)
- Flavonoids as inhibitors of rat liver monooxygenase activities. (1988) (56)
- Measurement of lipophilicity indices by reversed-phase high-performance liquid chromatography : comparison of two stationary phases and various eluents (1991) (56)
- L‐Dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's disease ‡ (1987) (55)
- Biochemistry of redox reactions (1995) (55)
- High-performance liquid chromatographic separation of the enantiomers of anti-inflammatory 2-arylpropionates: suitability of the method for in vitro metabolic studies. (1984) (55)
- Generalization of ionic partition diagrams to lipophilic compounds and to biphasic systems with variable phase volume ratios. (2001) (54)
- Theoretical Parameters to Characterize Antioxidants. Part 1. The case of vitamin E and analogs (1997) (53)
- The Biochemistry of Drug Metabolism — An Introduction. Part 2. Redox Reactions and Their Enzymes (2007) (52)
- Qualitative structure-metabolism relationships in the hydrolysis of carbamates (2010) (52)
- Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships. (1995) (51)
- Evidence for the existence of [3H]‐trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore (1998) (51)
- The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism. (1990) (50)
- The concept of molecular structure in structure–activity relationship studies and drug design (1991) (49)
- A stilbene and dihydrochalcones with radical scavenging activities from Loiseleuria procumbens. (2000) (49)
- Monoamine oxidase inhibitory activity of some Hypericum species native to South Brazil (2001) (48)
- The lipophilicity of deuterium atoms. A comparison of shake-flask and HPLC methods (1984) (48)
- Lipophilicity Plays a Major Role in Modulating the Inhibition of Monoamine Oxidase B by 7‐Substituted Coumarins (2006) (48)
- The Biochemistry of Drug Metabolism – An Introduction (2009) (47)
- Solute water interactions in the organic-phase of a biphasic system.1. Structural influence of organic solutes on the water-dragging effect (1993) (46)
- Microscopic Protonation/Deprotonation Equilibria of the Anti‐Inflammatory Agent Piroxicam (1995) (46)
- Pattern recognition study of QSAR substituent descriptors (1989) (45)
- Pharmacokinetic Profiling in Drug Research (2006) (45)
- Trimetazidine reverses calcium accumulation and impairment of phosphorylation induced by cyclosporine A in isolated rat liver mitochondria. (1996) (45)
- Xenobiotic metabolism by brain monooxygenases and other cerebral enzymes (1984) (45)
- Lipophilicity measurement of nicotinates by reversed-phase high-performance liquid chromatography : Differences in retention behaviour, but similarities of log kw values, in methanol-water and acetonitrile-water eluents (1987) (45)
- In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations. (2010) (45)
- The chromatographic analysis of enantiomers in drug metabolism studies. (1986) (45)
- Effects of charge and intramolecular structure on the lipophilicity of nitrophenols (1999) (44)
- Immobilized artificial membrane liquid chromatography: proposed guidelines for technical optimization of retention measurements. (2002) (44)
- Structural properties governing retention mechanisms on immobilized artificial membrane (IAM) HPLC columns (2002) (44)
- Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models. (1996) (43)
- The Biochemistry of Drug Metabolism — An Introduction. Part 4. Reactions of Conjugation and Their Enzymes (2009) (43)
- Novel pathways in drug metabolism. (1978) (43)
- The Apparent Lipophilicity of Quaternary Ammonium Ions Is Influenced by Galvani Potential Difference, Not Ion-Pairing: A Cyclic Voltammetry Study (2001) (42)
- X-ray crystallography and drug action: edited by A. S. Horn and C. J. De Ranter, Oxford University Press, 1984. £30.00 (xii + 514 pages) ISBN 0 19 855185 1 (1985) (42)
- Does an endogenous methylpyridinium analogue cause Parkinson's disease? (1985) (42)
- FAME 3: Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes (2019) (42)
- The Biochemistry of Drug Metabolism – An Introduction (2008) (41)
- Homology modeling of human serum carnosinase, a potential medicinal target, and MD simulations of its allosteric activation by citrate. (2006) (41)
- Different partitioning behaviour of sulphonyl-containing compounds in reversed-phase high-performance liquid chromatography and octanol-water systems (1988) (41)
- Lipophilicity Behaviour of the Zwitterionic Antihistamine Cetirizine in Phosphatidylcholine Liposomes/Water Systems (2001) (41)
- Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0 (2010) (41)
- Computational Approaches to Lipophilicity: Methods and Applications (2007) (40)
- Blood-to-Brain Transfer of Various Oxicams: Effects of Plasma Binding on Their Brain Delivery (1997) (40)
- A cellular automata model of enzyme kinetics. (1996) (40)
- Molecular electrostatic potentials for characterizing drug-biosystem interactions. (1991) (39)
- Theoretical and Experimental Exploration of the Lipophilicity of Zwitterionic Drugs in the 1,2-Dichloroethane/Water System (2002) (39)
- Structure–lipophilicity relationships of zwitterionic amino acids (1991) (38)
- Comparison of various non-polar stationary phases used for assessing lipophilicity (1989) (38)
- Development of molecular hydrogen-bonding potentials (MHBPs) and their application to structure-permeation relations. (2001) (37)
- Predicting the Oxidative Metabolism of Statins: An Application of the MetaSite® Algorithm (2007) (37)
- Structure-genotoxicity relationships of allylbenzenes and propenylbenzenes: a quantum chemical study. (1994) (37)
- Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. (1996) (36)
- Theoretical conformational studies on some dopamine antagonistic benzamide drugs: 3-pyrrolidyl- and 4-piperidyl derivatives. (1983) (36)
- Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. (1997) (36)
- Lipophilicity measurement by reversed-phase high-performance liquid chromatography (RP-HPLC): A comparison of two stationary phases based on retention mechanisms (2004) (35)
- Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. (1996) (35)
- Enantiomeric resolution of sulfoxides on a DACH-DNB chiral stationary phase: A quantitative structure-enantioselective retention relationship (QSERR) study (1993) (35)
- Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB1 cannabinoid receptor ligands and potential antagonists: Synthesis, lipophilicity, affinity, and molecular modeling : additions and corrections (2002) (35)
- The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety (1985) (35)
- Metabolic chiral inversion of anti-inflammatory 2-arylpropionates: lack of reaction in liver homogenates, and study of methine proton acidity. (1988) (34)
- Stereoselective drug metabolism and its significance in drug research. (1988) (34)
- The biochemistry of drug metabolism : principles, redox reactions, hydrolyses (2008) (34)
- PHARMACODYNAMICS, PHARMACOKINETICS AND TOXICITY OF IBUPROFEN ENANTIOMERS (1997) (34)
- Ionic Partition Diagram of the Zwitterionic Antihistamine Cetirizine (2001) (34)
- The Prediction of Substituent Interactions in the Lipophilicity of Disubstituted Benzenes using RP‐HPLC (1985) (34)
- Intramolecular Interactions Encoded in Lipophilicity: Their Nature and Significance (2008) (34)
- Substrate and product stereoselectivity in monooxygenase-mediated drug activation and inactivation. (1988) (34)
- Transfer Mechanism of Ionic Drugs: Piroxicam as an agent facilitating proton transfer (1996) (33)
- Mechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interactions. (1989) (33)
- Emergence and Dissolvence in the Self-organisation of Complex Systems (2000) (33)
- X-ray crystal structure, partitioning behavior, and molecular modeling study of piracetam-type nootropics: insights into the pharmacophore. (1995) (32)
- pH-dependency of basic ligand binding to α1-acid glycoprotein (orosomucoid) (1991) (32)
- Similarities of pharmacophoric patterns revealed by the MEP of metoclopramide, molindone and piquindone, a subgroup of dopamine D-2 receptor antagonists (1986) (32)
- Potent lipophilic substituted benzamide drugs are not selective D‐1 dopamine receptor antagonists in the rat (1983) (32)
- Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology (2014) (32)
- Mechanisms of Liposomes/Water Partitioning of (p-Methylbenzyl)alkylamines (1998) (31)
- [3H]‐Trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance (2000) (31)
- Predicting drug metabolism: Concepts and challenges (2004) (31)
- Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives. (2007) (31)
- Prodrugs revisited: The “ad hoc” approach as a complement to ligand design (1996) (31)
- The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents (1977) (30)
- Signs of the times: the need for a stereochemically informative generic name system. (1989) (30)
- Solvatochromic Analysis of the Retention Mechanism of two Novel Stationary Phases Used for Measuring Lipophilicity by RP-HPLC (1992) (30)
- Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1996) (29)
- Cellular automata models of biochemical phenomena (1999) (29)
- Organic Stereochemistry. Part 3 (2013) (29)
- Centrifugal counter-current chromatography, a promising means of measuring partition coefficients (1990) (29)
- Metabolic chiral inversion of ibuprofen in isolated rat hepatocytes. (1990) (29)
- The biochemistry of drug metabolism (2008) (29)
- Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (1995) (28)
- Drug Metabolism for the Perplexed Medicinal Chemist (2009) (28)
- In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations (2002) (28)
- Interaction of neuroleptic drugs with rat striatal D-1 and D-2 dopamine receptors: a quantitative structure—affinity relationship study (1988) (28)
- Structural effects in the lipophilicity of di- and polysubstituted benzenes as measured by reversed-phase high-performance liquid chromatography (1987) (28)
- pH-dependence of warfarin binding to alpha 1-acid glycoprotein (orosomucoid). (1993) (26)
- A systems approach to molecular structure, intermolecular recognition, and emergence‐dissolvence in medicinal research (1997) (26)
- Kinetics and Mechanisms of Racemization: 5-Substituted Hydantoins (= Imidazolidine-2,4-diones) as Models of Chiral Drugs (1996) (26)
- The pH-Partition Profile of the Anti-Ischemic Drug Trimetazidine May Explain Its Reduction of Intracellular Acidosis (1999) (26)
- Novel RPLC stationary phases for lipophilicity measurement: solvatochromic analysis of retention mechanisms for neutral and basic compounds. (2005) (26)
- Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis. (2012) (26)
- Design of intramolecularly activated prodrugs. (1998) (26)
- Determination of Lipophilicity and Hydrogen‐bond Donor Acidity of Bioactive Sulphonyl‐containing Compounds by Reversed‐phase HPLC and Centrifugal Partition Chromatography and their Application to Structure‐activity Relations (1991) (26)
- Solvatochromic analysis of di-n-butyl ether/water partition coefficients as compared to other solvent systems (1997) (25)
- ENZYMATIC HYDROLYSIS BY MOUSE SKIN HOMOGENATES: STRUCTURE-METABOLISM RELATIONSHIPS OF PARA-NITROBENZOATE ESTERS (1981) (25)
- Hepatocyte hollow‐fibre bioreactors: design, set‐up, validation and applications (2003) (25)
- Novel drug metabolites produced by functionalization reactions: chemistry and toxicology. (1978) (25)
- Protein Protection by Antioxidants: Development of a Convenient Assay and Structure-Activity Relationships of Natural Polyphenols (2002) (25)
- Quantitative structure-metabolism relationship analyses of MAO-mediated toxication of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and analogues. (1992) (25)
- Binding Space Concept: A New Approach To Enhance the Reliability of Docking Scores and Its Application to Predicting Butyrylcholinesterase Hydrolytic Activity. (2017) (25)
- Monoamine oxidase inhibitory properties of some benzazoles: Structure-; Activity relationships (1999) (24)
- Quantitative structure-activity relationships and eudismic analyses of the presynaptic dopaminergic activity and dopamine D2 and sigma receptor affinities of 3-(3-hydroxyphenyl)piperidines and octahydrobenzo[f]quinolines. (1987) (24)
- Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary (1987) (24)
- A cellular automata model of diffusion in aqueous systems. (1997) (24)
- Solvatochromic Analysis of Partition Coefficients in the o-Nitrophenyl Octyl Ether (o-NPOE)/Water System (2003) (24)
- Molecular electrostatic potential of orthopramides: implications for their interaction with the D-2 dopamine receptor. (1986) (23)
- Hepatic pharmacology: mechanisms of action and classification of antinecrotic hepatoprotective agents (1982) (23)
- The relative partitioning of neutral and ionised compounds in sodium dodecyl sulfate micelles measured by micellar electrokinetic capillary chromatography. (2002) (23)
- Solute water interactions in the organic-phase of a biphasic system.2. effects of organic-phase and temperature on the water-dragging effect (1994) (23)
- Structure-Lipophilicity and Structure-Polarity Relationships of Amino-Acids and Peptides (1995) (23)
- The concept of regioselectivity in drug metabolism (1976) (22)
- Muscarinic Receptors: A Comparative Analysis of Structural Features and Binding Modes through Homology Modelling and Molecular Docking (2006) (22)
- Synthesis and monoamine oxidase inhibitory activity of 3-substituted 5H-indeno[1,2-c]pyridazines (1993) (22)
- In vitro inhibition by stiripentol of rat brain cytochrome P-450-mediated naphthalene hydroxylation. (1988) (21)
- Musings on ADME Predictions and Structure–Activity Relations (2005) (21)
- H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles. (1997) (21)
- Substituted Xanthones as Selective and Reversible Monoamine Oxidase A (MAO-A) Inhibitors (1993) (21)
- A theoretical conformational study of substituted o‐anisamides as models of a class of dopamine antagonists (1981) (21)
- The Biochemistry of Drug Metabolism — An Introduction. Part 6. Inter-Individual Factors Affecting Drug Metabolism (2009) (21)
- Bicarbonate-catalyzed hydrolysis of hexamethylene diisocyanate to 1,6-diaminohexane. (1991) (21)
- Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. (1996) (21)
- ADME-Tox approaches (2007) (21)
- The Biochemistry of Drug Metabolism — An Introduction. Part 1. Principles and Overview (2007) (21)
- Low configurational stability of amfepramone and cathinone: Mechanism and kinetics of chiral inversion (1995) (20)
- Partition coefficients of ionizable compounds in o-nitrophenyl octyl ether/water measured by the potentiometric method. (2003) (20)
- Partition Coefficient and Molecular Flexibility: The Concept of Lipophilicity Space (2009) (20)
- Organic Stereochemistry. Part 2 (2013) (20)
- Toxication of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and analogs by monoamine oxidase. A structure-reactivity relationship study. (1990) (20)
- Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicity. (1993) (20)
- The Biochemistry of Drug Metabolism – An Introduction (2009) (20)
- The binding of agonists and antagonists to rat lung beta-adrenergic receptors as investigated by thermodynamics and structure-activity relationships. (1986) (20)
- A cellular automata model of ligand passage over a protein hydrodynamic landscape. (2002) (19)
- Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages (2015) (19)
- Use of centrifugal partition chromatography for assessing partition coefficients in various solvent systems (1989) (19)
- l‐Dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice ‡ (1987) (19)
- Human Serum Albumin Conformational Changes as Induced by Tenoxicam and Modified by Simultaneous Diazepam Binding (1993) (19)
- Interactions of anti-inflammatory 2-arylpropionates (profens) with the metabolism of fatty acids: in vitro studies. (1994) (19)
- The racemization of enantiopure drugs: Helping medicinal chemists to approach the problem (1997) (19)
- The Esterase-Like Activity of Serum Albumin May Be Due to Cholinesterase Contamination (2001) (19)
- Complexity and emergence in drug research (1995) (19)
- Theoretical Parameters to Characterize Antioxidants. Part 2. The cases of melatonin and carvedilol (1998) (18)
- Structure-reactivity relationships in the chemical hydrolysis of prodrug esters of nicotinic acid (1990) (18)
- Organic stereochemistry. Part 5 : Stereoselectivity in molecular and clinical pharmacology (2013) (18)
- The Biochemistry of Drug Metabolism — An Introduction. Part 3. Reactions of Hydrolysis and Their Enzymes (2007) (18)
- Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysis. (1992) (18)
- Exploring the space of histidine containing dipeptides in search of novel efficient RCS sequestering agents. (2013) (17)
- The solute-solvent system: solvent constraints on the conformational dynamics of acetylcholine. (2002) (17)
- L-DOPA esters as potential prodrugs. I: Physicochemical properties (1985) (17)
- The Partition Coefficient of Protonated Antihistamines. Its calculation and interpretation in terms of hydrophobic fragmental constants (1978) (17)
- Influence of Lipophilicity and Chirality on the Selectivity of Ligands for β1‐ and β2‐Adrenoceptors (1988) (17)
- Esters of L‐Dopa: Structure‐hydrolysis Relationships and Ability to Induce Circling Behaviour in an Experimental Model of Hemiparkinsonism (1995) (17)
- Inhibition of &agr;‐Ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1 ‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) (1995) (17)
- Physicochemical properties and transport behaviour of piribedil: Considerations on its membrane-crossing potential (1992) (17)
- The molecular behaviour of cetirizine (1997) (17)
- Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists. (1988) (16)
- Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors. (2004) (16)
- NMR conformational study of aminoalkylbenzamides, aminoalkyl-o-anisamides, and metoclopramide, a dopamine receptor antagonist (1984) (16)
- Aryl hydrocarbon hydroxylase in rat brain microsomes (1985) (16)
- The conformational and property space of acetylcholine bound to muscarinic receptors: an entropy component accounts for the subtype selectivity of acetylcholine. (2007) (16)
- Influence of Ionization State on the Activation of Temocapril by hCES1: A Molecular‐Dynamics Study (2009) (16)
- QSAR of nortropane-substituted benzamides: use of lipophilic (RP-HPLC) and electronic (1H NMR) parameters (1989) (16)
- Structural Factors Affecting the Basicity of ω-Pyridylalkanols, ω-Pyridylalkanamides and ω-Pyridylalkylamines (1982) (16)
- Recognition forces involved in mitochondrial binding to a low-affinity trimetazidine binding site related to anti-ischemic activity. (2002) (16)
- Ionization and Partitioning Profiles of Zwitterions: The case of the anti‐inflammatory drug azapropazone (1996) (15)
- Structural and electronic factors influencing the inhibition of aniline hydroxylation by alcohols and their binding to cytochrome P-450. (1981) (15)
- Solvent constraints on the property space of acetylcholine. I. Isotropic solvents. (2005) (15)
- Intrinsic and intramolecular lipophilicity effects in O-glucuronides (1998) (15)
- Interaction of psychotropic drugs with monoamine oxidase in rat brain (2001) (15)
- Lipophilicity Profiles of Ampholytes (1998) (15)
- Mechanism of ligand binding to alpha 1-acid glycoprotein (orosomucoid): correlated thermodynamic factors and molecular parameters of polarity. (1995) (15)
- Lipophilicity Behavior of Model and Medicinal Compounds Containing a Sulfide, Sulfoxide, or Sulfone Moiety. (1997) (15)
- Quantitative structure-activity relationships in drug metabolism and disposition: pharmacokinetics of N-substituted amphetamines in humans. (1980) (15)
- Development and Validation of an HPLC Method for the Simultaneous Monitoring of Bromazepam and Omeprazole (2008) (15)
- A cellular automata model of the hydrophobic effect. (1995) (15)
- Liver drugs : from experimental pharmacology to therapeutic application (1988) (15)
- Inhibiting or potentiating effects of flavonoids on carbon tetrachloride-induced toxicity in isolated rat hepatocytes. (1986) (15)
- Pharmacokinetic and pharmacodynamic events: can they always be distinguished? (1987) (15)
- Electrochemical Behavior and Antioxidant Activity of Some Natural Polyphenols. (1996) (15)
- Immobilized Artificial Membrane HPLC in Drug Research (2003) (14)
- MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data. (2017) (14)
- Water-dragging effect : a new experimental hydration parameter related to hydrogen-bond-donor acidity (1990) (14)
- Conformation, electrostatic potential and pharmacophoric pattern of orthopramides and other dopamine receptor antagonists (1986) (14)
- Influence of palmitate and benzoate on the unidirectional chiral inversion of ibuprofen in isolated rat hepatocytes. (1992) (14)
- Circular dichroic determination of the preferred conformation of nicotine and related chiral alkaloids in aqueous solution. (1973) (14)
- Structure‐Metabolism Relations and the Challenge of Predicting Biotransformation (2007) (14)
- Organic stereochemistry. Part 4 : isomerisms about single bonds and in cyclic systems (2013) (14)
- Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling. (2002) (14)
- Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits. (1993) (14)
- Basicity, Lipophilicity, and Lack of Receptor Interaction of N‐Aminoalkylbenzamides and N‐Aminoalkyl‐o‐anisamides as Model Compounds of Dopamine Antagonists (1983) (13)
- Thermodynamics and mechanism of partitioning of pyridylalkanamides in n-octanol/ water and di-n-butyl ether/water (1987) (13)
- Mechanisms and pharmaceutical consequences of processes of stereoisomerisation - A didactic excursion. (2016) (13)
- The development of a hydration factor ω and its relation to correction terms in current hydrophobic fragmental systems (1983) (13)
- A reappraisal of the stereoselective metabolism of nicotine to nicotine-1'-N-oxide. (1976) (13)
- Lipophilicity and Related Molecular Properties as Determinants of Pharmacokinetic Behaviour (2000) (13)
- Concepts in prodrug design to overcome pharmacokinetic problems. (2007) (13)
- Molecules as complex adaptative systems: constrained molecular properties and their biochemical significance. (2000) (13)
- Natural and Synthetic Xanthones as Monoamine Oxidase Inhibitors: Biological Assay and 3D-QSAR. (2001) (13)
- 8-Substituted Xanthines As Phosphodiesterase Inhibitors - Conformation-Dependent Lipophilicity and Structure-Activity-Relationships (1989) (13)
- Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonist. (1989) (13)
- Effects of solvation on the ionization and conformation of raclopride and other antidopaminergic 6-methoxysalicylamides: insight into the pharmacophore (1993) (13)
- Solvent constraints on the property space of acetylcholine. 2. Ordered media. (2005) (13)
- Botanical (morphological, micrographic), chemical and pharmacological characteristics of Pfaffia species (Amaranthaceae) native to South Brazil (2003) (13)
- PCILO and CD. Conformational study of sulpiride, a dopamine antagonist (1981) (13)
- Lipophilicity: The Empirical Tool and the Fundamental Objective. An Introduction (2008) (12)
- Criteria for the acceptability of experimental evidence for the enantiomeric composition of xenobiotics and their metabolites. (1987) (12)
- Isotope effects on the lipophilicity of deuterated caffeines (1989) (12)
- Types of stereoselectivity in drug metabolism: a heuristic approach (2015) (12)
- A Cellular Automata Model of Micelle Formation (1996) (12)
- Drug Racemization and Its Significance in Pharmaceutical Research (2003) (12)
- Studies of Ligand Diffusion Pathways over a Protein Surface (2003) (12)
- The Hydrolysis of Amides (2006) (12)
- The Biochemistry of Drug Metabolism: Conjugations, Consequences of Metabolism, Influencing Factors (2010) (12)
- The influence of conformational factors on the metabolic conjugation of aryloxyacetates (1986) (12)
- The development of a stable oral solution of captopril for paediatric patients (2007) (12)
- QSAR in drug metabolism and disposition. An application to the affinity for cytochrome P-450 and hepatic clearance of barbiturates. (1978) (12)
- Principles of Drug Metabolism 2: Hydrolysis and Conjugation Reactions (2007) (12)
- Novel Basic Isoflavones as Inhibitors of Bone Resorption (2001) (11)
- Quantitative Structure‐Affinity Relationships of Dopamine D2 Receptor Antagonists: A Comparison between Orthopramides and 6‐Methoxysalicylamides (1991) (11)
- Nonenzymatic contributions to xenobiotic metabolism. (1982) (11)
- pH-dependency of basic ligand binding to alpha 1-acid glycoprotein (orosomucoid). (1991) (11)
- Preparative separation of diastereoisomeric 2-arylpropionic acid derivatives by centrifugal thin-layer chromatography (1986) (11)
- Nicotinate Esters: Their Binding to and Hydrolysis by Human Serum Albumin (1992) (11)
- A Cellular Automata Model of the Percolation Process (1999) (11)
- Introduction: The Why and How of Drug Bioavailability Research (2008) (11)
- The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube (2009) (11)
- Principles of Drug Metabolism (2010) (10)
- Structure–Metabolism Relationships in the Hydrolysis of Nicotinate Esters by Rat Liver and Brain Subcellular Fractions (1991) (10)
- Development of a capillary electrophoresis method to monitor protein oxidation and antioxidant protection (1999) (10)
- Ex vivo inhibition of rat brain cytochrome P-450 activity by stiripentol. (1988) (10)
- Electronic and Conformational Effects on the Lipophilicity of Isomers and Analogs of the Neurotoxin 1‐Methyl‐4‐phenylpyridinium (MPP+) (1991) (10)
- Complex systems in drug research: II. The ligand - active site - water confluence as a complex system (1996) (10)
- Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses. (2005) (10)
- The Hydrolysis of Carboxylic Acid Ester Prodrugs (2006) (10)
- Clofibric acid increases the undirectional chiral inversion of ibuprofen in rat liver preparations. (1996) (10)
- A systems approach to molecular structure, intermolecular recognition, and emergence-dissolvence in medicinal research. (1997) (10)
- Atomic Diversity, Molecular Diversity, and Chemical Diversity: The Concept of Chemodiversity (2009) (10)
- Insight into the Lipophilicity of the Aromatic N-Oxide Moiety (1996) (10)
- The temperature dependence of steady-state kinetics: what can be learned about pig liver esterase stereospecificity? (1994) (10)
- Organic Stereochemistry. Part 8 (2013) (9)
- Development of an in Vitro Rat Intestine Segmental Perfusion Model to Investigate Permeability and Predict Oral Fraction Absorbed (2006) (9)
- Prodrug Objectives and Design (2007) (9)
- Toroidal coil centrifugal partition chromatography, a method for measuring partition coefficients. (1991) (9)
- Prediction of the Formation of Reactive Metabolites by A Novel Classifier Approach Based on Enrichment Factor Optimization (EFO) as Implemented in the VEGA Program (2018) (9)
- Mechanisms of inhibition of xenobiotic-metabolizing enzymes. (1990) (9)
- Dispersal (Entropy) and Recognition (Information) as Foundations of Emergence and Dissolvence (2009) (9)
- An ab initio study of electronic factors in metabolic hydroxylation of aliphatic carbon atoms. (1978) (9)
- Complex systems in drug research: I. The chemical levels (1996) (9)
- WHAT DIFFERENTIATES FREE AMINO ACIDS AND AMINOACYL RESIDUES? AN EXPLORATION OF CONFORMATIONAL AND LIPOPHILICITY SPACES (1999) (9)
- Structure-affinity relationships of baclofen and 3-heteroaromatic analogues. (1995) (9)
- Organic Stereochemistry. Part 1. Symmetry Elements and Operations, Classification of Stereoisomers (2013) (9)
- Chemodiversity and molecular plasticity: recognition processes as explored by property spaces. (2011) (9)
- Conformational constraints on side chains in protein residues increase their information content (2003) (9)
- Structure‐Property Relationships in the Basicity and Lipophilicity of Arylalkylamine Oxides (1999) (9)
- Valofan diastereoisomers: their analysis by high-performance liquid chromatography and interconversion wth proxibarbal in aqueous solution (1979) (9)
- Stereoselectivity in Metabolic Reactions of Toxication and Detoxication (1994) (8)
- Organic stereochemistry. Part 6 : the conformation factor in molecular pharmacology (2013) (8)
- Interactions between the in vitro metabolism of xenobiotics and fatty acids. The case of ibuprofen and other chiral profens. (1995) (8)
- The Biochemistry of Drug Metabolism — An Introduction. Part 5. Metabolism and Bioactivity (2009) (8)
- The Molecular Lipophilicity Potential (MLP): A New Tool for log P Calculations and Docking, and in Comparative Molecular Field Analysis (CoMFA) (2008) (8)
- A Fresh Look at Molecular Structure and Properties (2007) (8)
- Polar intermolecular interactions encoded in partition coefficients and their interest in QSAR (1993) (8)
- A continuous fluorimetric method to monitor the enzymatic hydrolysis of medicinal esters. (1996) (8)
- Organic Stereochemistry. Part 3. Other Stereogenic Elements: Axes of Chirality, Planes of Chirality, Helicity, and (E,Z)-Diastereoisomerism (2013) (8)
- Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database. (2019) (8)
- Chapter 1 The geometry of molecules: Basic principles and nomenclatures (1982) (8)
- Screening of the inhibitory effect of xenobiotics on alcohol metabolism using S9 rat liver fractions. (2012) (8)
- Modelling the Metabolic Epimerization of Anti‐inflammatory 2‐Arylpropanoyl‐coenzyme‐A Conjugates: Solvent effects on the 1H/2H exchange in S‐[2‐(dimethylamino)ethyl] 2‐phenylpropanethioate (1989) (8)
- The Electronic Structure of Dopamine. An ab initio Electrostatic Potential Study of the Catechol Moiety (1985) (8)
- Molecular-dynamics and NMR investigation of the property space of the zwitterionic antihistamine cetirizine (2001) (8)
- Organic Stereochemistry: Guiding Principles and Bio‐Medicinal Relevance (2013) (8)
- Conformational Fluctuations versus Constraints in Amino Acid Side Chains: The Evolution of Information Content from Free Amino Acids to Proteins (2006) (7)
- Organic Stereochemistry. Part 7 (2013) (7)
- Molecular modeling of hen egg lysozyme HEL[52-61] peptide binding to I-Ak MHC class II molecule. (1998) (7)
- Multivariate data modeling of new steric, topological and CoMFA-derived substituent parameters (1993) (7)
- Xenobiotic and endobiotic metabolizing enzymes: an overstretched discrimination? (1981) (7)
- Development of a method to investigate the hydrolysis of xenobiotic esters by a Mycobacterium smegmatis homogenate. (2011) (7)
- Solvent-dependent lipophilicity and hydrogen-bonding capacity of 2-pyridylalkanols (1989) (7)
- Stabilization of the Hydrophilic Sphere of lobitridol, an lodinated Contrast Agent, as Revealed by Experimental and Computational Investigations (1995) (7)
- Organic Stereochemistry. Part 2. Stereoisomerism Resulting from One or Several Stereogenic Centers (2013) (7)
- Pargyline Analogues as Potent, Non‐selective Monoamine Oxidase Inhibitors (1998) (7)
- Perspectives in Medicinal Chemistry (1993) (7)
- Effects of solvation on the ionization and conformation of raclopride and other antidopaminergic 6-methoxysalicylamides: insight into the pharmacophore. (1993) (7)
- Aryl ether O-dealkylase activity in the skin of untreated mice in vitro. (1981) (7)
- L-DOPA esters as potential prodrugs. II: Chemical and enzymatic hydrolysis (1985) (7)
- [Rheology in the study of Carbopol macromolecules interactions as well as the semi-guantitative determination of the ionic force of their dispersion]. (1973) (7)
- Some chemical and stereochemical aspects of diethylpropion metabolism in man. (1973) (7)
- Thermodynamic studies of enzyme catalysis. What can we learn about specificity and mechanism? (1994) (6)
- On flying wedges, crashing wedges, and perspective‐blind stereochemists (1991) (6)
- Chapter 24 – Biotransformation Reactions and their Enzymes (2015) (6)
- [Dissociation constants and activity coefficients of Carbopols during their potentiometric titration]. (1972) (6)
- Metabolic investigations of proxibarbal [5-allyl-5-(2-hydroxypropyl)barbituric acid] in vitro. (1980) (6)
- Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group. (2003) (6)
- Ionization behavior and ionization-dependent conformation of raclopride, a dopamine-D2 receptor antagonist (1991) (6)
- Biotransformation Reactions and Their Enzymes (2008) (6)
- Convenient method for the analysis of nicotinic acid as a metabolite of nicotinate esters in various tissue homogenates. (1989) (6)
- Proceedings of an International Symposium on Chirality and Biological Activity held at Tübingen, Germany, on 5-8 April 1988. (1990) (6)
- A Conformational Study of Antihistaminic Pheniramines in Solution (1974) (5)
- 31 – BIOTRANSFORMATION REACTIONS (2003) (5)
- The influence of aromatic substituents on the binding of substituted benzamides to dopamine D‐2 receptors: congruent QSAR and MEP analyses (1987) (5)
- Dual ligand binding of pyridylalkanamides to microsomal cytochrome P-450. (1986) (5)
- Organic Stereochemistry. Part 8. Prostereoisomerism and the Concept of Product Stereoselectivity in Biochemistry and Xenobiotic Metabolism (2013) (5)
- The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro (1988) (5)
- A Cellular Automata Model of Water Structuring by a Chiral Solute (2002) (5)
- A Cellular Automata Model of the Hydrophobia Effect (1995) (5)
- The influence of hydration and structure-promoting effects on the viscosity of binary solvent mixtures (1988) (5)
- Mechanisms of chiral recognition in pharmacology: the Easson-Stedman model revisited (1990) (5)
- Influence of stereochemical factors on the partition coefficient of diastereoisomers in a biphasic octan-1 ol-water system (1993) (4)
- Use of molecular lipophilicity potential for the prediction of log P (1994) (4)
- Valuable Data + Competent Presentation = Good Science (1997) (4)
- Chiral recognition in biochemical pharmacology: An overview (2003) (4)
- Physicochemical and Structural Properties of Non-Steroidal Antiinflammatory Oxicams. (1993) (4)
- Activation of benzoate model prodrugs by mycobacteria. Comparison with mammalian plasma and liver hydrolysis. (2021) (4)
- Conjugations, consequences of metabolism, influencing factors (2010) (4)
- CHAPTER 5 – Nonenzymatic Biotransformation (1983) (4)
- Variation, Natural Selection, and Information Content – A Simulation (2007) (4)
- Introduction: Metabolic Hydrolysis and Prodrug Design (2006) (4)
- The concept of emergence—dissolvence in drug research (1997) (4)
- Structure-Lipophilicity Relationships of Zwitterionic Amino Acids. (1992) (4)
- Organic Stereochemistry. Part 7. The Concept of Substrate Stereoselectivity in Biochemistry and Xenobiotic Metabolism (2013) (4)
- The Hydrogen Bonding of Drugs: Its Experimental Determination and Role in Pharmacokinetics and Pharmacodynamics (1992) (3)
- The Hydrolysis of Carboxylic Acid Esters (2006) (3)
- Synthesis, biological activity and molecular modelling of the 53-54 ketomethylene analogue of HEL(52-61) (1998) (3)
- [Chirality and drugs]. (2000) (3)
- Molecular toxicology and the medicinal chemist. (1998) (3)
- Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugs. (1987) (3)
- Emergent chemodiversity: The case of stereoisomerism in acyclic alkanes. (2017) (3)
- VolSurf and Its Application in Structure‐Disposition Relationships (2007) (3)
- The lipophilicity behaviour of COMT inhibitors (2002) (3)
- X‐Ray and 1H‐NMR Configurational Assignment of Valofan (α‐Allphanoyl‐α‐allyl‐γ‐valerolactone) Diastereoisomers (1984) (3)
- Centrifugal Partition Chromatography for Lipophilicity Measurements (2008) (3)
- Small Molecules as Exemplars of Emergent Properties and Diversification into the ‘Adjacent Possible’ (2014) (3)
- Lipophilicity and hydrogen-bonding capacity : their role in drug-binding and disposition (1993) (2)
- Metabolism in Drug Development (2014) (2)
- Benzoic Acid Derivatives as Prodrugs for the Treatment of Tuberculosis (2021) (2)
- Chirality and biological activity : proceedings of an international symposium held at Tubingen, Federal Republic of Germany, April 5-8, 1988 (1990) (2)
- Selective Inhibitors of Monoamine Oxidase (MAO‐A and MAO‐B) as Probes of Its Catalaytic Site and Mechanism (1995) (2)
- The effect of cianidanol on rat hepatic monooxygenase activities. (1983) (2)
- Classification, Localization, and Some Physiological Roles of Hydrolytic Enzymes (2006) (2)
- The Hydrogen-Bond: computational approaches and applications to drug design. (2002) (2)
- Lack of enantioselectivity in the SULT1A3-catalyzed sulfoconjugation of normetanephrine enantiomers: an in vitro and computational study. (2013) (2)
- Hydration of substituted benzenes. Experimental studies and relationship with lipophilicity (1989) (2)
- The Hydration of Epoxides (2006) (2)
- The description of rheological curves by a simple empirical function and its calculation by multiple regression. (1978) (2)
- Chirality in Drug Research. Edited by Eric Francotte and Wolfgang Lindner. (2007) (2)
- Catalytic Mechanisms of Hydrolytic Enzymes (2006) (2)
- Stereoselectivity in Drug Disposition and Metabolism: Concepts and Mechanisms (1991) (2)
- Simulations in Evolution. II. Relative Fitness and the Propagation of Mutants (2009) (2)
- The Reversible Proxibarbal-Valofan Isomerisation. Part I. Kinetic and thermodynamic studies in aqueous solutions (1988) (2)
- Solvent-dependent conformation of cyclosporin a: evidence from partition coefficients and molecular dynamics simulations (1993) (2)
- THEORETICAL CONFORMATIONAL STUDIES OF SOME DOPAMINE ANTAGONISTIC BENZAMIDE DRUGS: 3-PYRROLIDYL- AND 4-PIPERIDYL DERIVATIVES (1983) (2)
- Stereoselective metabolism and toxicology of pyrethroids. (1990) (2)
- VolSurf and its interest in structure-disposition relations. (2001) (2)
- To Monty Kier, a friendly tribute. (2012) (2)
- The Reversible Proxibarbal‐Valofan Isomerisation. Part II. Kinetic studies in a biphasic octanol/water system (1988) (2)
- Influence of lipophilicity and chirality on the selectivity of ligands for beta 1- and beta 2-adrenoceptors. (1988) (2)
- Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide (2014) (1)
- The Cleavage of Esters of Inorganic Acids (2006) (1)
- Regioelectronic factors in metabolic hydroxylation of aliphatic carbon atoms. (1978) (1)
- Pharmacokinetic Lead Optimization: Fine Art vs. Blind Technology (2007) (1)
- The Concept of Emergence‐Dissolvence in Drug Research (1997) (1)
- Multivariate data analyses of QSAR parameters. (1989) (1)
- Molecules and Meaning : How Do Molecules Become Biochemical Signals ? (2002) (1)
- Pharmaceutical Sciences, Scientist, and Journals—A Tribute to Pharmaceutical Research for Its Coming of Age (2005) (1)
- Lipophilicity and conformational behaviour of substituted xanthines. (1989) (1)
- Molecular properties and structure‐permeation relations revisited (1998) (1)
- Affinity of pyridylalkylamines for nicotinic, muscarinic and histaminic recognition sites in brain tissue preparations. (1986) (1)
- Isotope Effects on Lipophilicity and Polarity (1988) (1)
- Measurement of partition-coefficients using centrifugal partition chromatography : method development and application to the determination of solute structural-properties (1993) (1)
- Drug metabolism as a mutation--drug metabolism in mutation. (1976) (1)
- [Dichroic and conformational study of ephedrine, pseudoephedrine and of various analogues]. (1973) (1)
- Chirality in drug research - stereomania, stereophobia, or stereophilia (1993) (1)
- The Hydrolysis of Peptides: Sections 6.1 – 6.3 (2006) (1)
- 3D modelling of soybean glyoxysomal malate dehydrogenase (1993) (1)
- Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection (2021) (1)
- Comprar The Biochemistry of Drug Metabolism: Volume 2: Conjugations, Consequences of Metabolism, Influencing Factors | Bernard Testa | 9783906390543 | Wiley (2009) (1)
- Formulation optimization in a university hospital : The example of pediatric solutions of the ACE inhibitor captopril (2005) (1)
- Medicinal Chemistry: A Teacher's and Worker's Perspective (1992) (1)
- Handbook of stereoisomers: Therapeutic drugs: edited by Donald F. Smith, CRC Press, 1989. £166.00 (405 pages) ISBN 0 8493 3421 7 (1990) (1)
- Organic Stereochemistry. Part 4. Isomerisms about Single Bonds and in Cyclic Systems (2013) (1)
- Miscellaneous Reactions of Hydration and Dehydration (2006) (1)
- Three-dimensional and electronic analysis of Na+-dependent antidopaminergic agents: tropapride and zetidoline (1986) (1)
- Monoamine oxidase inhibitor properties of some benzazoles: structure-activity relationships. (1999) (1)
- Preface: Text and Context (1988) (1)
- Preface: “Not Known, Because Not Looked For” (1990) (1)
- Organic Stereochemistry. Part 5. Stereoselectivity in Molecular and Clinical Pharmacology (2013) (1)
- Role of Phase I Metabolism in Drug Activation and Clinical Treatment Outcomes (2012) (1)
- Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study (1984) (1)
- Approaching Pharmacological Space: Events and Components. (2018) (1)
- The Many Faces of Pharmaceutical Research (1995) (1)
- Molecular hydrogen-bonding potentials (MHBPs) in structure-permeation relations (2001) (1)
- Emerging Chemodiversity and Stereoisomerism in Acyclic Mono‐ and Dichloroalkanes (2018) (0)
- Interview with a Distinguished Pharmaceutical Scientist: Bernard Testa (1999) (0)
- Organic Stereochemistry. Part 6. The Conformation Factor in Molecular Pharmacology (2013) (0)
- N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing such derivatives (1997) (0)
- The Biochemistry of Drug Metabolism – An Introduction (2009) (0)
- Professor André Collet 1945-1999. (2000) (0)
- The Hydrolysis of Peptides: Sections 6.4 – 6.6 (2006) (0)
- A Cellular Automata Study of Constraints (Dissolvence) in a Percolating Many-Particle System (2001) (0)
- New derivatives of N-benzylpiperazine, their process for the preparation and pharmaceutical compositions containing them (2001) (0)
- MetaPies , an annotated database for metabolism analysis and prediction : results and future perspectives (2011) (0)
- A graphical similarity function to help ligand docking to proteins based on the molecular lipophilicity potential : the case of the D 2 dopamine receptor (2004) (0)
- The Reversible Proxibarbal-Valofan Isomerization. Part 1. Kinetic and Thermodynamic Studies in Aqueous Solutions. (1988) (0)
- BASICITY, LIPOPHILICITY, AND LACK OF RECEPTOR INTERACTION OF N-AMINOALKYLBENZAMIDES AND N-AMINOALKYL-O-ANISAMIDES AS MODEL COMPOUNDS OF DOPAMINE ANTAGONISTS (1983) (0)
- [Chiral drugs: pharmacological tools and/or therapeutic problems?]. (1990) (0)
- 1 Metabolism in Drug Development (2014) (0)
- Preface: “One Score Volumes, and a Diet” (1991) (0)
- Obituary: Joachim M. Mayer (1949-2001) (2001) (0)
- Preface to Volume 5 (2007) (0)
- Clinical pharmacology and therapeutics: edited by Paul Turner, Macmillan Publishers, 1980. £40.00 (xvi + 576 pages) ISBN 0 335 31229 5 (paper) (1982) (0)
- N-Benzylpiperazinverbindungen, to processes for their preparation and compositions containing them (1994) (0)
- New compounds n-benzylpiperazine, their preparation process and pharmaceutical compositions including them. (1994) (0)
- WELCOME TO THE XIITH INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY (1992) (0)
- Synthesis, Biological Activity and Molecular Modelling of the 53-54 Ketomethylene Analogue ofHEL(52-61) . . (1998) (0)
- AN AB INITIO STUDY OF ELECTRONIC FACTORS IN METABOLIC HYDROXYLATION OF ALIPHATIC CARBON ATOMS (1978) (0)
- New N-benzylpiperazinforbindelser, process for their preparation and pharmaceutical compositions containing them (2002) (0)
- Erratum: Editor's note: Professor Andre Collet 1945–1999 (2000) (0)
- Molecular lipophilicity potential as a tool in 3D QSAR: Method development and applications (1993) (0)
- New derivatives of N-benzylpiperazine, method of preparing them and pharmaceutical compositions containing them (1996) (0)
- Inhibition of Monoamine Oxidase‐B by 5H‐Indeno(1,2‐c)pyridazines: Biological Activities, Quantitative Structure‐Activity Relationships ( QSARs) and 3D‐QSARs. (1996) (0)
- Molecular volumes in chemistry and biology: Applications including partitioning and toxidty: J. C. McGowan and A. Mellors, Ellis Horwood, 1986. £35 (vi + 259 pages) ISBN 0 7458 0081 5 (1987) (0)
- N-benzylpiperazinderivate, processes for their preparation and pharmaceutical compositions containing them (1997) (0)
- Beta-adrenoceptor modeling based on MEP studies. (1989) (0)
- Synthesis and Monoamine Oxidase Inhibitory Activity of 3‐Substituted 5H‐Indeno(1,2‐c)pyridazines. (1993) (0)
- ERRATUM (2004) (0)
- Simulations in Evolution. III. Randomness as a Generator of Opportunities (2013) (0)
- Additions et corrections : structure genotoxicity relationships of allylbenzenes and propenylbenzenes - A quantum-chemical Study (1995) (0)
- Synthesis and MAO Inhibitory Activity of New Pyridazine-, Pyrimidine- and 1,2,4-Triazine-Containing Tricyclic Derivatives (2007) (0)
- PCILO AND CD CONFORMATIONAL STUDY OF SULPIRIDE, A DOPAMINE ANTAGONIST (1982) (0)
- Evaluation of intravenous drug compatibilities in an adult intensive care unit (2009) (0)
- Ionization Behavior and Ionization-Dependent Conformation of Raclopride, a Dopamine D2 Receptor Antagonist. (2010) (0)
- Biological models to study blood-brain barrier permeation (2001) (0)
- Conclusion: The Biochemistry of Water (2006) (0)
- Synthesis and Pharmacochemical Investigation of Some New Arylethanolamines as α3‐Adrenoceptor Ligands (1998) (0)
- Intrinsic and Intramolecular Lipophilicity Effects in O‐Glucuronides. (1998) (0)
- Editorial—Views and Reviews (1993) (0)
- Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques (1988) (0)
- A Systems Approach to Molecular Structure, Intermolecular Recognition, and Emergence-Dissolvence in Medicinal Research (2010) (0)
- Interactions between the in vitro metabolism of xenoblotics and fatty acids—The case of ibuprofen and other chiral profems (1994) (0)
- Editorial (2009) (0)
- The Reversible Proxibarbal-Valofan Isomerization. Part 2. Kinetic Studies in a Biphasic Octanol/Water System (1988) (0)
- [Molecular lipophilicity potential (MLP) in drug design. Complementing theoretical tools with experimental results]. (1996) (0)
- 8-Substituted Xanthines as Phosphodiesterase Inhibitors: Conformation-Dependent Lipophilicity and Structure-Activity Relationships (1989) (0)
- Preface: “All Mimsy Were the Borogoves” (1992) (0)
- Effect of topically applied phenobarbital on O-dealkylase activity in mouse skin (1982) (0)
- Preface: At The Funfair? (1989) (0)
- [Behavior of the system boric acid-sodium acetate]. (1970) (0)
- Modelling the Metabolic Epimerization of Antiinflammatory 2-Arylpropanoyl-coenzyme-A Conjugates: Solvent Effects on the 1H/2H Exchange in S-(2-(Dimethylamino)ethyl) 2-Phenylpropanethioate. (1989) (0)
- Preface: “Poking the Fire” (1991) (0)
- Editorial: Chemistry Probing Nature (2004) (0)
- A Great Year behind Us, a Bright Future ahead (2005) (0)
- X-RAY AND PROTON NMR CONFIGURATIONAL ASSIGNMENT OF VALOFAN (α-ALLOPHANOYL-α-ALLYL-Γ-VALEROLACTONE) DIASTEREOISOMERS (1984) (0)
- The Concept of Property Space: The Case of Acetylcholine (2007) (0)
- N-benzylpiperazinforbindelser, process for their preparation and compositions containing the compounds (1994) (0)
- Lack of Enantioselectivity in the SULT 1 A 3-catalyzed Sulfoconjugation of Normetanephrine Enantiomers : An In Vitro and Computational Study (2012) (0)
- The Hydrolysis of Lactams (2006) (0)
- Preface: Circles in drug research (1996) (0)
- Molecular modeling in drug design : funny, futile, Or fertile (1994) (0)
- The effect of xenobiotics on rat liver alcohol dehydrogenase activity or how medicines can affect the metabolism of alcohol (2009) (0)
- The Concept of Molecular Structure in Structure-Activity Relationship Studies and Drug Design (1991) (0)
- [Potentiometric study of hydrogels of Carbopol 940 neutralized by some basic active principles]. (1974) (0)
- [Pharmacological modulation of mitochondrial oxidative phosphorylation: inhibition by cyclosporine A, restoration by trimetazidine]. (1996) (0)
- Preparation and Stability of Mycobacterium tuberculosis and Mycobacterium smegmatis homogenates for studies of prodrug activation (2006) (0)
- Technology Update: IV Drugs (2009) (0)
- Deprenyl inthemanagementofresponsefluctuations inpatients withParkinson's disease on levodopa (1980) (0)
- Stabilization of the hydrophilic sphere of iobitridol. (2003) (0)
- Preface: The Search for Consensus (1997) (0)
- Reversible inhibition of MAO-A and B by diazoheterocyclic compounds: Development of QSAR/CoMFA models (2000) (0)
- In silico prediction of metabolism by human carboxylesterase-1 (hCES1) combining docking analyses and MD simulations (2009) (0)
- Partitioning behaviour of piracetam-type cognition enhancers (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernard Testa?
Bernard Testa is affiliated with the following schools: